Showing results (31-40 of 141) with videos related to
Sort By:
Pageof 15
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 14, 2007
Bortezomib is active in patients with untreated or relapsed Waldenstrom's macroglobulinemia: a phase II study of the National Cancer Institute of Canada Clinical Trials GroupChristine I Chen, C Tom Kouroukis, Darrell White, et al.Haematologica|October 19, 2010
Phase I study of sorafenib in patients with refractory or relapsed acute leukemiasGautam Borthakur, Hagop Kantarjian, Farhad Ravandi, et al.Investigational New Drugs|March 13, 2014
Randomized phase II trial of sorafenib alone or in combination with carboplatin/paclitaxel in women with recurrent platinum sensitive epithelial ovarian, peritoneal, or fallopian tube cancerAnita Schwandt, Vivian E von Gruenigen, Robert M Wenham, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2008
Tolerability, pharmacodynamics, and pharmacokinetics studies of depsipeptide (romidepsin) in patients with acute myelogenous leukemia or advanced myelodysplastic syndromesVirginia M Klimek, Sophia Fircanis, Peter Maslak, et al.Journal of the American Chemical Society|July 13, 2017
Retuning the Catalytic Bias and Overpotential of a [NiFe]-Hydrogenase via a Single Amino Acid Exchange at the Electron Entry/Exit SiteHope Adamson, Martin Robinson, John J Wright, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 2006
Cardiac studies in patients treated with depsipeptide, FK228, in a phase II trial for T-cell lymphomaRichard L Piekarz, A Robin Frye, John J Wright, et al.Clinical and Translational Science|April 28, 2018
Sorafenib Dose Recommendation in Acute Myeloid Leukemia Based on Exposure-FLT3 RelationshipTao Liu, Vijay Ivaturi, Philip Sabato, et al.Cancer|October 21, 2010
A phase 1-2 study of a farnesyltransferase inhibitor, tipifarnib, combined with idarubicin and cytarabine for patients with newly diagnosed acute myeloid leukemia and high-risk myelodysplastic syndromeElias Jabbour, Hagop Kantarjian, Farhad Ravandi, et al.Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|June 27, 2006
A rapid and sensitive method for determination of sorafenib in human plasma using a liquid chromatography/tandem mass spectrometry assayMing Zhao, Michelle A Rudek, Ping He, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 26, 2011
Pediatric phase I trial and pharmacokinetic study of dasatinib: a report from the children's oncology group phase I consortiumRichard Aplenc, Susan M Blaney, Lewis C Strauss, et al.Pageof 15